globenewswire.com

Reputation Factor: 3.16 High
Sites Owned: 3
Total Reference Links: 115
Total Citations: 127
Unique Wikipedia Articles Citing: 116

Associated Sites

globenewswire.com

Uncategorized

Links: 1

Citations: 1

ml-eu.globenewswire.com

Uncategorized

Links: 3

Citations: 3

www.globenewswire.com

News

Links: 111

Citations: 123

Top Reference Links

Score	Article	Site	Category	Cited In (Articles)
6.3	U.S. FDA grants accelerated approval to Boehringer's Hernexeos as first orally administered targeted therapy for previously treated patients with HER2-mutant advanced NSCLC https://www.globenewswire.com/news-release/2025/08/08/3130334/0/en/U-S-FDA-grants-accelerated-approval-to-Boehringer-s-HERNEXEOS-as-first-orally-administered-targeted-therapy-for-previously-treated-patients-with-HER2-mutant-advanced-NSCLC.html	www.globenewswire.com	News	2
6.3	Chips&Media Completes Development of Next-Gen 'AV2' HW Decoder IP, Accelerating Global Market Leadership https://www.globenewswire.com/news-release/2026/06/10/3309684/0/en/Chips-Media-Completes-Development-of-Next-Gen-AV2-HW-Decoder-IP-Accelerating-Global-Market-Leadership.html	www.globenewswire.com	News	2
6.3	Galle Gallants Announce New Ownership Under Gallant Sports and Media LLC https://www.globenewswire.com/news-release/2026/05/04/3286576/0/en/galle-gallants-announce-new-ownership-under-gallant-sports-and-media-llc-within-urban-gro-flash-sports-media-ipg-operated-lpl-season-6-ecosystem-pubudu-dassanayake-appointed-head-c.html	www.globenewswire.com	News	2
6.3	PharmAla Executes Binding Letter of Intent for Formation of Special Purpose Vehicle to Develop Patented Novel MDXX Molecule APA-01 https://www.globenewswire.com/news-release/2026/04/27/3281580/0/en/PharmAla-Executes-Binding-Letter-of-Intent-for-Formation-of-Special-Purpose-Vehicle-to-Develop-Patented-Novel-MDXX-Molecule-APA-01.html	www.globenewswire.com	News	2
6.3	Crinetics Announces FDA Approval of Palsonify (paltusotine) for the Treatment of Adults with Acromegaly https://www.globenewswire.com/news-release/2025/09/25/3156767/0/en/Crinetics-Announces-FDA-Approval-of-PALSONIFY-paltusotine-for-the-Treatment-of-Adults-with-Acromegaly.html	www.globenewswire.com	News	2
6.3	Citi(R) Presents A Very Special Performance from Coldplay at the Beacon Theatre https://www.globenewswire.com/en/news-release/2014/04/24/1002696/0/en/Citi-R-Presents-a-Very-Special-Performance-From-Coldplay-at-the-Beacon-Theatre.html	www.globenewswire.com	News	2
3.1	AFRICA OIL PROVIDES UPDATE ON PUNTLAND DRILLING https://www.globenewswire.com/news-release/2012/05/17/263848/0/sv/AFRICA-OIL-PROVIDES-UPDATE-ON-PUNTLAND-DRILLING.html	www.globenewswire.com	News	1
3.1	SCO Film and Television Week Kicks Off -- In Qingdao, Connecting the World through Cinema https://www.globenewswire.com/news-release/2025/08/25/3138186/0/en/SCO-Film-and-Television-Week-Kicks-Off-In-Qingdao-Connecting-the-World-through-Cinema.html	www.globenewswire.com	News	1
3.1	Maziar Mike Doustdar appointed as president and chief executive officer of Novo Nordisk https://www.globenewswire.com/news-release/2025/07/29/3123141/0/en/Maziar-Mike-Doustdar-appointed-as-president-and-chief-executive-officer-of-Novo-Nordisk.html	www.globenewswire.com	News	1
3.1	INVESTOR ALERT: Shareholder Class Action Lawsuit Filed Against Ibotta https://www.globenewswire.com/news-release/2025/04/24/3067840/0/en/INVESTOR-ALERT-Shareholder-Class-Action-Lawsuit-Filed-Against-Ibotta-Inc-NYSE-IBTA-DiCello-Levitt-LLP-Encourages-Investors-with-Losses-to-Discuss-Their-Options-with-Counsel.html	www.globenewswire.com	News	1

Citation Trends Over Time